Free Trial
NASDAQ:TLRY

Tilray Brands (TLRY) Stock Price, News & Analysis

Tilray Brands logo
$1.61 -0.05 (-2.72%)
Closing price 04:00 PM Eastern
Extended Trading
$1.62 +0.01 (+0.93%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tilray Brands Stock (NASDAQ:TLRY)

Advanced

Key Stats

Today's Range
$1.59
$1.88
50-Day Range
$0.57
$1.85
52-Week Range
$0.35
$1.88
Volume
117.76 million shs
Average Volume
45.88 million shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.94
Consensus Rating
Hold

Company Overview

Tilray Brands Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

TLRY MarketRank™: 

Tilray Brands scored higher than 52% of companies evaluated by MarketBeat, and ranked 695th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tilray Brands has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Tilray Brands has a consensus price target of $1.94, representing about 19.2% upside from its current price of $1.63.

  • Amount of Analyst Coverage

    Tilray Brands has only been the subject of 2 research reports in the past 90 days.

  • Read more about Tilray Brands' stock forecast and price target.
  • Earnings Growth

    Earnings for Tilray Brands are expected to grow in the coming year, from ($0.20) to ($0.10) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tilray Brands is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tilray Brands is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tilray Brands has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Tilray Brands' valuation and earnings.
  • Percentage of Shares Shorted

    14.04% of the outstanding shares of Tilray Brands have been sold short.
  • Short Interest Ratio / Days to Cover

    Tilray Brands has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tilray Brands has recently decreased by 4.58%, indicating that investor sentiment is improving.
  • Dividend Yield

    Tilray Brands does not currently pay a dividend.

  • Dividend Growth

    Tilray Brands does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.04% of the outstanding shares of Tilray Brands have been sold short.
  • Short Interest Ratio / Days to Cover

    Tilray Brands has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tilray Brands has recently decreased by 4.58%, indicating that investor sentiment is improving.
  • News Sentiment

    Tilray Brands has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 30 news articles for Tilray Brands this week, compared to 13 articles on an average week.
  • Search Interest

    90 people have searched for TLRY on MarketBeat in the last 30 days. This is an increase of 29% compared to the previous 30 days.
  • MarketBeat Follows

    99 people have added Tilray Brands to their MarketBeat watchlist in the last 30 days. This is an increase of 120% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tilray Brands insiders have bought more of their company's stock than they have sold. Specifically, they have bought $120,750.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.60% of the stock of Tilray Brands is held by insiders.

  • Percentage Held by Institutions

    Only 9.35% of the stock of Tilray Brands is held by institutions.

  • Read more about Tilray Brands' insider trading history.
Receive TLRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray Brands and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TLRY Stock News Headlines

CBD oil cannabis extract, Hemp oil bottles and hemp flowers on a wooden table, Medical cannabis concept — Photo
Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?
Tilray's stock surge, fueled by political commentary and a technical squeeze, is now focusing market attention on its strong financial health.
Tilray Brands Target of Unusually High Options Trading (NASDAQ:TLRY)
Front-Run Buffett's Shocking Gold Move
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.tc pixel
Tilray Stock Is Trading Higher Monday: What's Going On?
See More Headlines

TLRY Stock Analysis - Frequently Asked Questions

Tilray Brands' stock was trading at $1.33 at the beginning of 2025. Since then, TLRY stock has increased by 22.2% and is now trading at $1.6250.

Tilray Brands, Inc. (NASDAQ:TLRY) issued its earnings results on Monday, July, 28th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.05. The business had revenue of $224.54 million for the quarter, compared to the consensus estimate of $250.41 million. Tilray Brands had a negative net margin of 265.69% and a negative trailing twelve-month return on equity of 6.83%.
Read the conference call transcript
.

Tilray Brands (TLRY) raised $135 million in an IPO on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tilray Brands investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), Humana (HUM), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
7/28/2025
Today
10/02/2025
Next Earnings (Estimated)
10/09/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TLRY
Previous Symbol
NASDAQ:TLRY
CIK
1731348
Fax
N/A
Employees
2,842
Year Founded
2013

Price Target and Rating

High Price Target
$3.00
Low Price Target
$1.00
Potential Upside/Downside
+17.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.19 billion
Net Margins
-265.69%
Pretax Margin
-280.33%
Return on Equity
-6.83%
Return on Assets
-5.45%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
2.46
Quick Ratio
1.49

Sales & Book Value

Annual Sales
$821.31 million
Price / Sales
2.22
Cash Flow
$0.14 per share
Price / Cash Flow
11.97
Book Value
$1.40 per share
Price / Book
1.18

Miscellaneous

Outstanding Shares
1,100,530,000
Free Float
1,093,927,000
Market Cap
$1.82 billion
Optionable
Optionable
Beta
1.98

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:TLRY) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners